US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 1042.690
  • +2.730+0.26%
Close Sep 27 16:00 ET
  • 1042.690
  • 0.0000.00%
Post 20:02 ET
114.94BMarket Cap27.61P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Regeneron Pharmaceuticals Q2 2024 Earnings Date

Currency：USDAug 1, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
3.39B
3.55B
+159.94M
Beat Est.
+7.25%
+12.32%
+4.72%
EPS
8.27
12.41
+4.14
Beat Est.
-2.74%
+46.00%
+50.11%
Analyst Rating
Strong Buy

Sep 27, 2024

Regeneron Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 20 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 3.785B--
Oct 31, 20242024/Q3-- / 3.655B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--
Feb 2, 20242023/Q43.434B / 3.287B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 3.785B--
Oct 31, 20242024/Q3-- / 3.655B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--
Feb 2, 20242023/Q43.434B / 3.287B--

Unlock Free Earnings Estimates

Regeneron Pharmaceuticals Earnings Reports

  • Regeneron Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1 07:21 ET

  • Regeneron Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 2 07:18 ET

  • Regeneron Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 5 09:17 ET

  • Regeneron Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 07:22 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 27, 2024

    Strong Buy

    • Buy

      95.00%

    • Hold

      0.00%

    • Sell

      5.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Infectious Disease
    Infectious Disease
    Intraday0.00%